Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer; SOPHIA

Press/Media: Press / Media

Period2018 Oct 2

Media coverage

1

Media coverage

  • TitleMargetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer; SOPHIA
    Media name/outletClinical Trials.gov
    Country/TerritoryUnited States
    Date18/10/2
    PersonsYoungWan Kim, YoungKeun Kim
View all 1
View less